Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Concurrent Opioid Use Disorder and Major Depressive Disorder
NCT04177706Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Dec 2020
- Primary completion
- Nov 2022
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in major depressive disorder (MDD), opioid use disorder (OUD), sponsored by Medical University of South Carolina. Started Dec 2020; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04177706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04177706.